Skip to main content

Avatar OE 2023 Update 44

Product Requirements and Recommendations

Avatar CWS required
Avatar OE required
RADplus required

Recommended Update Level

Avatar CWS 2023 Monthly Release 2023.04.00
Avatar OE 2023 Monthly Release 2023.04.00
RADplus 2023 Monthly Release 2023.04.00

Product Update Description

An issue is resolved in the Order Entry Console (Orders This Episode and Admission Med Reconciliation sections) where screening for 'Drug-Drug Interactions' may not be performed against orders already in the Scratchpad when selecting a medication for a new order. This issue occurs when "Drug-Drug Interactions" are not selected in the 'Types of Screening Performed Via Direct CKO Server Connection' prompt in the 'Order Entry Clinical Screening System Defaults' form.

Required Updates

None

Included Updates

None

Details

NEW0 CHANGED0 FIXED1
Fixed (1)
Order Entry Console - Drug-to-Drug Interaction Warning
An issue is resolved in the Order Entry Console (Orders This Episode and Admission Med Reconciliation sections) where screening for 'Drug-Drug Interactions' may not be performed against orders already in the Scratchpad when selecting a medication for a new order. This issue occurs when "Drug-Drug Interactions" are not selected in the 'Types of Screening Performed Via Direct CKO Server Connection' prompt in the 'Order Entry Clinical Screening System Defaults' form.
KB0075720 v0.01
Topics
• Clinical Screening • NX
 
Acceptance Tests

AV-93845 Summary | Details
Order Entry Console - Drug-to-Drug Interaction Warning
Note - These testing guidelines assume the user is skilled in the use of, at a minimum, the following:
  • Order Code Setup
  • Order Entry Console - Interactions
  • Order Entry Console - Warning Dialog - Age/Problem
  • Order Entry Console - Warning Dialog - Consent
  • Order Entry Console - Warning Dialog - Non-Formulary
  • Orders This Episode
  • Order Entry Clinical Screening System Defaults
  • Home Medications
  • Order Entry Console
  • Order Entry Console - Admission Med Reconciliation
Scenario 1: OE NX - Alert Interaction Checking in the Order Entry Console
Specific Setup:
  • A client must have an active episode. (Client A)
  • “Client A” must have a ‘Date of Birth’, ‘Sex’ and address on file in the ‘Update Client Data’ form, as well as information filed in the ‘Allergies and Hypersensitivities’ form, ‘Diagnosis’ form, and in the ‘Height’ and ‘Weight’ fields in the ‘Vitals Entry’ form.
  • An order code for Advil must have the following configured in the 'Order Code Setup' form: (Order Code A)
  • 'Require Consent' = "Yes".
  • 'Alert When Client is Below Age' = "An age older than "Client A"".
  • 'Is this Medication a Formulary Item?' = "No".
Steps
  1. Select "Client A" and access the Order Entry Console.
  2. Search for and select "Warfarin Sodium et COUMADIN 2.5 MG ORAL" from the 'New Order' field.
  3. Fill out all required fields and click [Add to Scratchpad].
  4. Search for and select "Order Code A" from the 'New Order' field.
  5. Fill out all required fields and click [Add to Scratchpad].
  6. Click [Sign].
  7. Validate the 'Warning' dialog is displayed.
  8. Validate there is an 'Interaction' tab that contains a Drug Interaction for "Order Code A" and "Warfarin Sodium et COUMADIN 2.5 MG ORAL".
  9. Validate there is a 'Consent' tab for "Order Code A".
  10. Validate there is a 'Non-Formulary' tab for "Order Code A".
  11. Validate there is an 'Age and Problem Alert' tab for "Order Code A".
  12. Set the 'Notes' field for all tabs to any value and click [Save Override and Exit]
  13. Validate the 'Order grid' contains an order for "Order Code A" and "Warfarin Sodium et COUMADIN 2.5 MG ORAL".
Scenario 2: OE Console - OTE - Drug-to-Drug Interaction Checking - 'Types of Screening Performed Via Direct CKO Server Connection' = ""
Specific Setup:
  • There must be nothing checked in the 'Types of Screening Performed Via Direct CKO Server Connection' field in the 'Order Entry Clinical Screening System Default' form.
  • 'Active' must be the only thing checked in the 'Include Orders With The Following Order Statuses In Clinical Screening' field in the 'Order Entry Clinical Screening System Default' form.
  • A client must have an active episode. (Client A)
  • “Client A” must have a ‘Date of Birth’, ‘Sex’ and address on file in the ‘Update Client Data’ form, as well as information filed in the ‘Allergies and Hypersensitivities’ form, ‘Diagnosis’ form, and in the ‘Height’ and ‘Weight’ fields in the ‘Vitals Entry’ form.
Steps
  1. Select "Client A" and access the Order Entry Console.
  2. Search for and select "Warfarin Sodium et COUMADIN 2.5 MG ORAL" from the 'New Order' field.
  3. Fill out all required fields and click [Add to Scratchpad].
  4. Search for and select "ASPIRIN MICRO-COATED 325 MG TABLET ORAL" from the 'New Order' field.
  5. Validate there is an 'At least one warning has been found with this order code' button present below the 'New Order' field.
  6. Fill out all required fields and click [Add to Scratchpad].
  7. Click [Sign].
  8. Validate the 'Warning' dialog is displayed.
  9. Validate there is an 'Interaction' tab that contains a Drug Interaction for "ASPIRIN MICRO-COATED 325 MG TABLET ORAL" and "Warfarin Sodium et COUMADIN 2.5 MG ORAL".
  10. Set the 'Notes' field to any value and click [Save Override and Exit]
  11. Validate the 'Order grid' contains an order for "ASPIRIN MICRO-COATED 325 MG TABLET ORAL" and "Warfarin Sodium et COUMADIN 2.5 MG ORAL".
Scenario 3: OE Console - AMR - Drug-to-Drug Interaction Checking - 'Types of Screening Performed Via Direct CKO Server Connection' = ""
Specific Setup:
  • There must be nothing checked in the 'Types of Screening Performed Via Direct CKO Server Connection' field in the 'Order Entry Clinical Screening System Default' form.
  • 'Active' must be the only thing checked in the 'Include Orders With The Following Order Statuses In Clinical Screening' field in the 'Order Entry Clinical Screening System Default' form.
  • A client must have an active episode. (Client A)
  • “Client A” must have a ‘Date of Birth’, ‘Sex’ and address on file in the ‘Update Client Data’ form, as well as information filed in the ‘Allergies and Hypersensitivities’ form, ‘Diagnosis’ form, and in the ‘Height’ and ‘Weight’ fields in the ‘Vitals Entry’ form.
  • "Client A" must have no medications listed in the 'Home Medications' tab.
Steps
  1. Select "Client A" and access the Order Entry Console.
  2. Search for and select "Warfarin Sodium et COUMADIN 2.5 MG ORAL" from the 'New Order' field.
  3. Fill out all required fields, click [Add to Scratchpad] and [Sign].
  4. Select the 'Home Medications' tab.
  5. Check the 'No Known Medications' and 'Medication history reviewed and completed for Episode #x' fields.
  6. Select the 'Admission Reconciliation' tab.
  7. Search for and select "ASPIRIN MICRO-COATED 325 MG TABLET ORAL" from the 'New Order' field.
  8. Validate there is an 'At least one warning has been found with this order code' button present below the 'New Order' field.
  9. Fill out all required fields, click [Add to Scratchpad] and [Reconcile & Sign].
  10. Validate the 'Warning' dialog is displayed.
  11. Validate there is an 'Interaction' tab that contains a Drug Interaction for "ASPIRIN MICRO-COATED 325 MG TABLET ORAL" and "Warfarin Sodium et COUMADIN 2.5 MG ORAL".
  12. Set the 'Notes' field to any value and click [Save Override and Exit].
  13. Validate the 'Inpatient Medications Scratchpad' contains orders for "Warfarin Sodium et COUMADIN 2.5 MG ORAL" and "ASPIRIN MICRO-COATED 325 MG TABLET ORAL".
Topics
• Clinical Screening • NX